<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05055089</url>
  </required_header>
  <id_info>
    <org_study_id>PI2021_843_0186</org_study_id>
    <nct_id>NCT05055089</nct_id>
  </id_info>
  <brief_title>Short- and Medium-term Results of New Generation Aortic</brief_title>
  <acronym>RVANG</acronym>
  <official_title>Short- and Medium-term Outcomes of New Generation Biological Aortic Valves in Aortic Valve Replacement Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Over the past decade, aortic valve replacement surgery has undergone significant changes in&#xD;
      terms of both the approaches and the prostheses used. In parallel with the historical&#xD;
      biological prostheses for aortic valve surgery, a new generation of bioprostheses has been&#xD;
      marketed since 2008, with the entry of these new prostheses in the armatorium of the&#xD;
      Amiens-Picardy University Hospital since 2010. These are rapid deployment prostheses or&#xD;
      prostheses without sutures. As a result, patients undergoing aortic valve replacement have&#xD;
      been able to benefit from this type of bioprosthesis during their procedures. There are few&#xD;
      publications reporting the 5-year follow-up of these bioprostheses. The investigators&#xD;
      therefore decided to follow up patients operated on by a new generation bioprosthesis to&#xD;
      study the 5-year survival and the functioning of their bioprostheses, in order to make a&#xD;
      scientific contribution to the follow-up of these valves. These patients will be compared to&#xD;
      patients who have benefited from the implantation of traditional bioprostheses.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Variation of mortality rate between both groups</measure>
    <time_frame>3 months</time_frame>
    <description>both groups are :&#xD;
Patients undergoing surgical aortic valve replacement with new-generation bioprostheses&#xD;
Patients who received a traditional bioprosthesis</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">172</enrollment>
  <condition>Echocardiography</condition>
  <condition>Aortic Valve</condition>
  <condition>Cardiac Surgery</condition>
  <condition>Mortality</condition>
  <arm_group>
    <arm_group_label>new-generation bioprostheses</arm_group_label>
    <description>Patients undergoing surgical aortic valve replacement with new-generation bioprostheses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>traditional bioprosthesis</arm_group_label>
    <description>patients who received a traditional bioprosthesis</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients from the Cardiac Surgery Department of the University Hospital of Amiens of&#xD;
        Picardy, France, short- and medium-term survival of patients undergoing surgical aortic&#xD;
        valve replacement with new-generation bioprostheses compared with patients who received a&#xD;
        traditional bioprosthesis.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Retrospectively included all patients examined since 2010.&#xD;
&#xD;
          -  Patients who have aortic valve surgery from the Cardiac Surgery Department of the&#xD;
             University Hospital of Amiens.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal to participate in the patient.&#xD;
&#xD;
          -  Patients who have previously had aortic valve surgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Joseph NADER, MD</last_name>
    <phone>03220735937</phone>
    <email>nader.joseph@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens Nord</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Nader, MD</last_name>
      <phone>0322035937</phone>
      <email>nader.joseph@chu-amiens.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 14, 2021</study_first_submitted>
  <study_first_submitted_qc>September 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 23, 2021</study_first_posted>
  <last_update_submitted>September 14, 2021</last_update_submitted>
  <last_update_submitted_qc>September 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Echocardiography</keyword>
  <keyword>Aortic valve</keyword>
  <keyword>New-generation bioprosthesis</keyword>
  <keyword>Conventional bioprosthesis</keyword>
  <keyword>Rapid-deployment bioprosthesis</keyword>
  <keyword>Sutureless valves</keyword>
  <keyword>Function prostheses</keyword>
  <keyword>Cardiac Surgery</keyword>
  <keyword>Mortality</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

